Advertisement

Topics

FDA Approves First Non-Opioid For Management Of Opioid Withdrawal Symptoms

09:21 EDT 17 May 2018 | Pharmaceutical Processing

In clinical trials, Lucemyra significantly reduced the severity of withdrawal symptoms compared to placebo.
Staff Author: 

Original Article: FDA Approves First Non-Opioid For Management Of Opioid Withdrawal Symptoms

NEXT ARTICLE

More From BioPortfolio on "FDA Approves First Non-Opioid For Management Of Opioid Withdrawal Symptoms"

Advertisement
Quick Search
Advertisement
Advertisement